RECENT NEWS
Results of The HPTN 035 TrialFinal HIV results of Ushercell Trials Presented at IAS Conference in Sydney
Update on lime juice as a microbicide in The Economist
Not-for-Profit Approach Improves Prospect of Vaccines and Drugs for the Poor.
Standardization of Colposcopy for the Evaluation of Vaginal Products
Microbicides 2008 ConferenceFebruary 24-27, 2008
New Delhi, India
CONRAD'S 2006-2007 BIENNIAL REPORT
PRESS RELEASES
CONRAD Receives $100 Million from USAID for Microbicide Development
Gates Foundation
Give CONRAD
$28.5M for Microbicide Research
RECENT MEETINGS
Reproductive Health 2007 ConferenceSeptember 26-29, 2007
Minneapolis, MN
American Public Health Association
Annual Meeting and Exposition
November 3-7, 2007
Washington, DC
RECENT PUBLICATIONS
New England Journal of Medicine article of the results of the Phase 3 HIV effectiveness trial of cellulose sulfate
JOB OPPORTUNITY
Medical Officer Position
CONRAD exists to facilitate the rapid development of safe, acceptable, affordable products and methods that provide contraception and/or prevent the sexual transmission of HIV/AIDS and other infections.
Our work does not begin in the laboratory or even in the scientist's mind, but with the needs of women and men everywhere who are struggling for a better life for themselves and their families. As a multifaceted organization involved in all aspects of product development, we place high priority on those needs, doing much of our work in real settings, with real people. Our broad scope, global network and focus on reproductive health enables us to help to ensure that the emerging and changing needs of women and men in under-resourced parts of the world are acted on in swift and prudent ways.
Read the entire letter from the Executive Director
AS OF OCTOBER 14, 2008
CONRAD IS MOVING
OUR NEW ADDRESS IS:
CONRAD
1911 North Fort Myer Drive, Suite 900
Arlington, VA 22209
Telephone: (703) 524-4744
Fax: (703) 524-4770
E-mail: info@conrad.org